Democritus University of Thrace (DUTH)
Σύνδρομο αποφρακτικών απνοιών-υποπνοιών στον ύπνο και καρδιαγγειακοί παράγοντες κινδύνου. Επίδραση της θεραπείας με CPAP
Abstract
dc:descriptionBackground: Serum cardiovascular risk factors’ levels are elevated in patients with Obstructive Sleep Apnea Hypopnea Syndrome (OSAHS). Deregulation of glucose homeostasis, and insulin resistance have also been associated with OSAHS. These factors are mainly studied in patients before application of Continuous Positive Airway Pressure (CPAP) treatment. No data exist, however, concerning the modification of those factors, according to CPAP compliance. The aim of the study was a) to detect differences between OSAHS patients and healthy controls in levels of serum cardiovascular risk and glucose regulation factors. b) to explore possible correlations between these levels and patients’ demographic and sleep characteristics and c) to examine the effect of compliance to CPAP therapy on the levels of these factors. Methods: Patients (n=53) with newly diagnosed OSAHS by polysomnography, non-smokers, without comorbidities or medication use, at baseline or during the follow up period were included. Serum cardiovascular risk and glucose regulation factors were measured at baseline and 6 months after CPAP application. At the 6-month follow-up visit, patients were classified into three groups according to CPAP use: Group 1: good compliance (use per night ?4 h), Group 2: poor compliance (use per night <4 h), and Group 3: refusal of CPAP treatment. Thirty healthy subjects (AHI<5/h, non-smokers, without comorbidities or medication use) consisted the control group. Results: Patients (47 males and 6 females) had mean age (±SD) 46.09±10.87 years. They had in comparison to the control group a greater BMI (p<0.000) and greater circumference of neck (p=0.013), waist (p=0.044) and hip (p=0.046). Levels of hs-CRP (p=0.003), total cholesterol/HDL-C (p=0.040) and ApoB/ApoA-I (p<0.000), as well as levels of factors related with glucose regulation [fasting glucose (p<0.000), HbA1C (p=0.004), insulin (p<0.000), HOMAIR index (p<0.000)] were significantly higher compared to controls. A significantly higher percentage among OSAHS patients compared to controls fulfilled the criteria of metabolic syndrome (p<0.005). Indexes of hypoxia during sleep, such as average SpO2 and minimum SpO2 were strongly correlated with both cardiovascular risk and glucose homeostasis regulation factors; whereas AHI was only correlated positively with uric acid levels. At the 6-month follow-up in Group 1 (n=20), a significant decrease in the levels of hs-CRP (p=0.03), of uric acid (p=0.045), of homocysteine (p=0.005), of total cholesterol (p=0.021), of the ApoB/ApoA-I ratio (p=0.021), of the total cholesterol/HDL-C ratio (p=0.018) and of HbA1C (p=0.003) was observed. Group 2 (n=19) manifested only a smaller decrease in homocysteine values (p=0.021). In Group 3 (n=14), no significant changes were recorded. Conclusions: Patients with OSAHS manifest elevated levels of certain cardiovascular risk factors and glucose homeostasis regulation factors. Compliance to CPAP treatment reduces significantly the levels of hs-CRP, uric acid, homocysteine, total cholesterol, HbA1C, the total cholesterol/HDL-C and ΑpoB/ΑpoA-I ratios reducing the overall risk for cardiovascular disease risk.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2007
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Steiropoulos, Paschalis
- Στειρόπουλος, Πασχάλης
Subjects
dc:subject × 20- Σύνδρομο αποφρακτικών απνοιών-υποπνοιών ύπνου
- Καρδιαγγειακοί παράγοντες κινδύνου
- Συνεχής θετική πίεση αεραγωγών
- Συμμόρφωση
- Χοληστερόλη
- Ομοκυστεΐνη
- C-αντιδρώσα πρωτεΐνη υψηλής ευαισθησίας
- Γλυκοζυλιωνένη αιμοσφαιρίνη {HBA1}
- Obstructive sleep apnea-hypopnea syndrome
- Cardiovascular risk factors
- CPAP
- Compliance
- Cholesterol
- Homocysteine
- High-sensitivity C-reactive protein
- HbA1C
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/21063